Global Biosimulation Market- By Component (Software and Services), By Application (Drug Development, Drug Discovery, and Other Applications), By Delivery Mode (Ownership Models and Subscription Models), By End-User (Contract Research Organizations (CROs), Regulatory Authorities, Biotech Companies, Pharma Companies, and Other End Users), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
- Published date: Oct 2023
- Report ID: 53570
- Number of Pages: 312
- Format:
-
-
-
- Simulation Plus, Inc.
- Physiomics Plc
- Rosa & Co. LLC
- Dassault Systèmes SE
- Instem Group of Companies
- Schrödinger, Inc.
- Genedata AG
- BioSimulation Consulting Inc.
- Other Key Players.
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible